Application 211355
- Type
- ANDA
- Sponsor
- SOFGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OMEGA-3-ACID ETHYL ESTERS | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 62559-410 | Omega-3-Acid Ethyl Esters | Omega-3-Acid Ethyl Esters | ANI Pharmaceuticals, Inc. | ANDA | Current |
| 62559-410 | Omega-3-Acid Ethyl Esters | Omega-3-Acid Ethyl Esters | ANI Pharmaceuticals, Inc. | ANDA | Current |
| 62559-410 | Omega-3-Acid Ethyl Esters | Omega-3-Acid Ethyl Esters | ANI Pharmaceuticals, Inc. | ANDA | Current |
| 62559-410 | Omega-3-Acid Ethyl Esters | Omega-3-Acid Ethyl Esters | ANI Pharmaceuticals, Inc. | ANDA | Current |